RAPP · Insider trading · 13F holders · Congress trades
Rapport Therapeutics, Inc. (RAPP)
Who is buying and selling RAPP: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 12
- Insider buys, 90 days
- $1.7M
- Insider sales, 90 days
- $6.9M
- Congress trades, 12 months
- 0
RAPP at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 9 RAPP insiders filed 6 open-market purchases worth $1.7M and 9 sales worth $6.9M on SEC Form 4; 9 of the sales were pre-planned under Rule 10b5-1.
- 12 13F filers hold RAPP among their 50 largest positions, worth $591.4M combined, including Joseph Edelman and Julian and Felix Baker. The biggest bets by portfolio weight are ARCH Venture Management, LLC (14.1%), Johnson & Johnson (7.9%) and Cormorant Asset Management, LP (5.7%).
- No member of Congress has disclosed a trade in RAPP.
- RAPP last closed at $24.21 on Oct 29, 2026.
RAPP insider trading
Between Aug 1, 2026 and Oct 29, 2026, 9 RAPP insiders filed 6 open-market purchases worth $1.7M and 9 sales worth $6.9M on SEC Form 4; 9 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 23, 2026 | Sanchez Ramiro | Director | Buy | 3,600 | $27.35 | $98K | SEC |
| Oct 23, 2026 | Ceesay Abraham | Chief Executive Officer, Director | Sale10b5-1 | 2,210 | $29.16 | $64K | SEC |
| Oct 22, 2026 | Paul Steven M | Director | Buy | 35,714 | $27.28 | $974K | SEC |
| Oct 22, 2026 | Maraganore John | Director | Buy | 9,411 | $26.45 | $249K | SEC |
| Oct 22, 2026 | Young Wendy B. | Director | Buy | 3,789 | $26.39 | $100K | SEC |
| Oct 22, 2026 | Silva Paul M | Director | Buy | 3,680 | $27.08 | $100K | SEC |
| Oct 21, 2026 | Ignelzi Troy A. | Chief Financial Officer | Buy | 5,500 | $26.10 | $144K | SEC |
| Oct 8, 2026 | Ceesay Abraham | Chief Executive Officer, Director | Sale10b5-1 | 4,522 | $31.68 | $143K | SEC |
| Oct 1, 2026 | Gault Cheryl | Chief Operating Officer | Sale10b5-1 | 10,000 | $33.19 | $332K | SEC |
| Sep 24, 2026 | Ceesay Abraham | Chief Executive Officer, Director | Sale10b5-1 | 2,210 | $39.17 | $87K | SEC |
| Sep 9, 2026 | Ceesay Abraham | Chief Executive Officer, Director | Sale10b5-1 | 8,210 | $45.61 | $374K | SEC |
| Aug 26, 2026 | Yeleswaram Krishnaswamy | Chief Development Officer | Sale10b5-1 | 50,160 | $50.47 | $2.5M | SEC |
| Aug 26, 2026 | Ceesay Abraham | Chief Executive Officer, Director | Sale10b5-1 | 18,921 | $49.57 | $938K | SEC |
| Aug 20, 2026 | Yeleswaram Krishnaswamy | Chief Development Officer | Sale10b5-1 | 404 | $49.90 | $20K | SEC |
| Aug 12, 2026 | Ceesay Abraham | Chief Executive Officer, Director | Sale10b5-1 | 51,499 | $47.25 | $2.4M | SEC |
Who owns RAPP? Hedge funds and superinvestors
12 13F filers hold RAPP among their 50 largest positions, worth $591.4M combined, including Joseph Edelman and Julian and Felix Baker. The biggest bets by portfolio weight are ARCH Venture Management, LLC (14.1%), Johnson & Johnson (7.9%) and Cormorant Asset Management, LP (5.7%).
Superinvestors holding RAPP: Joseph Edelman 0.5% · Julian and Felix Baker 0.3%
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| ARCH Venture Management, LLCVenture capital | 14.1% | $155.4M | 3,728,738 | +0.0% shares | Q2 2026 |
| Cormorant Asset Management, LPHedge fund | 5.7% | $110.7M | 2,657,521 | -10.1% shares | Q2 2026 |
| Sofinnova Investments, Inc.Hedge fund | 4.2% | $79.4M | 1,904,408 | +0.0% shares | Q2 2026 |
| Julian and Felix BakerHedge fund | 0.3% | $64.5M | 1,547,090 | +0.0% shares | Q2 2026 |
| Johnson & JohnsonCorporation | 7.9% | $60.0M | 1,784,517 | +0.0% shares | Q3 2026 |
| Joseph EdelmanHedge fund | 0.5% | $32.2M | 773,342 | — | Q2 2026 |
| Vestal Point Capital, LPHedge fund | 0.7% | $30.4M | 730,000 | -49.2% shares | Q2 2026 |
| Siren, L.L.C.Investment manager | 0.5% | $26.7M | 641,469 | +0.0% shares | Q2 2026 |
| Sio Capital Management, LLCHedge fund | 2.2% | $12.8M | 307,657 | -16.1% shares | Q2 2026 |
| Burkehill Global Management, LPHedge fund | 0.4% | $10.4M | 250,000 | +0.0% shares | Q2 2026 |
| Artia Global Partners LPHedge fund | 1.1% | $5.8M | 138,508 | +0.0% shares | Q2 2026 |
| DAFNA Capital Management LLCHedge fund | 0.6% | $3.1M | 75,000 | +0.0% shares | Q2 2026 |
Each manager counts with its latest 13F (Q3 2026: 1, Q2 2026: 11). Screen RAPP in the grand portfolio →
RAPP stock trades by members of Congress
No member of Congress has disclosed a trade in RAPP.
Analysis mentioning RAPP
Posts from the blog that cover Rapport Therapeutics, Inc., newest first.
- Insider buying · Oct 23, 2026Insider Buying on October 23, 2026: CRBG, RENT and NXG Lead $21.2M of Purchases
- Insider buying · Oct 22, 2026Insider Buying on October 22, 2026: DOLE, CRBG and RAPP Lead $27.6M of Purchases
- Insider buying · Oct 21, 2026Insider Buying on October 21, 2026: GXVIX, CRBG and BPRE Lead $39.2M of Purchases
RAPP questions and answers
Are insiders buying RAPP stock?
Between Aug 1, 2026 and Oct 29, 2026, 9 RAPP insiders filed 6 open-market purchases worth $1.7M and 9 sales worth $6.9M on SEC Form 4; 9 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own RAPP?
12 13F filers hold RAPP among their 50 largest positions, worth $591.4M combined, including Joseph Edelman and Julian and Felix Baker. The biggest bets by portfolio weight are ARCH Venture Management, LLC (14.1%), Johnson & Johnson (7.9%) and Cormorant Asset Management, LP (5.7%).
Has Congress traded RAPP?
No member of Congress has disclosed a trade in RAPP.
Who is the largest holder of RAPP?
Among 13F filers, ARCH Venture Management, LLC reports the largest RAPP position, $155.4M (3,728,738 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is ARCH Venture Management, LLC's: 14.1% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.